Understanding Facility Validation for GMP compliance - Indian ...
Understanding Facility Validation for GMP compliance - Indian ...
Understanding Facility Validation for GMP compliance - Indian ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Article<br />
<strong>Understanding</strong> <strong>Facility</strong> <strong>Validation</strong> <strong>for</strong><br />
<strong>GMP</strong> <strong>compliance</strong><br />
*J.Ramniwas, CEO<br />
Sai Pharma Solutions Inc., Vadodara.<br />
Introduction<br />
In the past decade, many farreaching<br />
changes have taken place in<br />
the application of c<strong>GMP</strong> regulations<br />
relating to the pharmaceutical industry.<br />
Continuous quality improvement thus<br />
is ingrained in the c<strong>GMP</strong> concept. The<br />
design, construction, commissioning, and<br />
validation of pharmaceutical facilities play<br />
a very important role in the risk mitigation<br />
of product quality and safety.<br />
<strong>Facility</strong> qualification (a part of validation<br />
that proves and documents that equipments<br />
or ancillary systems are properly installed,<br />
work correctly, and actually lead to the<br />
expected results) and validation (establishing<br />
documented evidence that provides a high<br />
degree of assurance that the manufacturing<br />
processes, including buildings, systems,<br />
and equipment consistently produce the<br />
desired results according to predetermined<br />
specifications and quality attributes)<br />
activities establish and provide documentary<br />
evidence that the facility is suitable <strong>for</strong> the<br />
intended use of manufacturing, testing and<br />
storage, meeting <strong>GMP</strong> requirements.<br />
The journey of facility validation starts<br />
from the conceptual design in mind, then<br />
on the piece of paper, be<strong>for</strong>e it takes the<br />
concrete shape. The facility validation<br />
protocol should cover the following<br />
in<strong>for</strong>mation but not limited to:<br />
1. Purpose<br />
2. Reason <strong>for</strong> establishing the protocol <strong>for</strong><br />
facility qualification<br />
3. Protocol Approval Signatures<br />
4. Scope<br />
5. <strong>Validation</strong> Team and Responsibilities<br />
Design Qualification<br />
The premises, supporting utilities,<br />
equipment, and processes have to<br />
be designed in accordance with the<br />
requirements of <strong>GMP</strong>. Design Qualification<br />
(DQ) consists of:<br />
1. <strong>Facility</strong> design in brief<br />
2. Critical attributes to be met while<br />
designing the facility<br />
3. Location and surroundings<br />
4. Premises<br />
4.1 Room number<br />
4.2 Activity to be per<strong>for</strong>med<br />
4.3 Room classification (e.g., class<br />
100, 10,000, etc.)<br />
4.4 Utilities required and their quality<br />
(e.g., WFI, distilled water,<br />
compressed air, etc.)<br />
4.5 Room finishes (floor, walls,<br />
ceilings, partitions)<br />
4.6 Illumination level requirement<br />
4.7 Safety features<br />
4.8 Pass-through<br />
4.9 Communicators<br />
4.10 Prefabricated partitions<br />
5. Paints<br />
6. Doors and view panels<br />
7. Electrical requirements<br />
8. Equipments<br />
Installation Qualification<br />
The premises, supporting utilities, and<br />
equipment have to be built and installed in<br />
<strong>compliance</strong> with their design specifications.<br />
This constitutes Installation Qualification<br />
(IQ). Purpose of installation qualification is<br />
to establish documented evidence that the<br />
facility has been designed and constructed<br />
as intended and deviations, if any, are<br />
justified & recorded. The facility Installation<br />
Qualification Protocol should cover the<br />
following details but not limited to:<br />
1. Purpose<br />
2. <strong>Facility</strong> layout<br />
3. Major facility verification<br />
3.1 <strong>Facility</strong> <strong>compliance</strong> assessment <strong>for</strong><br />
location, surrounding and premises<br />
3.2 Room datasheets<br />
3.3 Verification and confirmation of<br />
termite treatment/ pest control<br />
certificate<br />
4. Materials of Construction (MOC)<br />
5. Verification of utility supply<br />
6. Identification of facility and their status<br />
review<br />
7. Verification <strong>for</strong> facility installation<br />
8. Drawings<br />
9. Standard Operating System (SOPs)<br />
Identification<br />
10. Deficiency (if any) and corrective action<br />
report<br />
11. Justification <strong>for</strong> the changes in facility<br />
layout<br />
12. Deviations (if any)<br />
13. Acceptance criteria<br />
Operational Qualification<br />
The facilities, supporting utilities, and<br />
equipments operate in accordance with<br />
their design specifications. This constitutes<br />
Operational Qualification (OQ). Every<br />
room/ section on each floor shall be<br />
checked <strong>for</strong> flawless and smooth functioning<br />
of the following as applicable. Any<br />
discrepancy shall be identified, corrected<br />
and documented. The facility Operational<br />
Qualification Protocol should cover the<br />
following details but not limited to:<br />
1. Opening of doors<br />
2. Closing of doors<br />
3. Door Locks<br />
4. Door handles and hinges<br />
5. Door closure<br />
6. Light sources and their fixtures<br />
7. Illumination<br />
8. Electrical points and their earthing<br />
9. Water points<br />
10. Compressed air use points<br />
11. Air handling units/ HVAC systems<br />
12. Temperature<br />
13. Differential Pressure<br />
14. Drain Points<br />
15. Verification of Standard Operating<br />
Procedures<br />
16. Training Documentation<br />
17. Acceptance Criteria<br />
*Email id: jramniwas@saipharmasolutions.com<br />
Pharma Times - Vol. 44 - No. 02 - February 2012 13
Per<strong>for</strong>mance Qualification<br />
Per<strong>for</strong>mance Qualification of various<br />
support services provided in each<br />
room is detailed in the respective utility<br />
protocols. The preventive maintenance<br />
and routine cleaning and sanitization of<br />
facility is also the part of the per<strong>for</strong>mance<br />
qualification.<br />
Requalification Criteria<br />
1. Any change/ modification that is made<br />
in the facility design or layout must<br />
be requalified. The affected area<br />
shall be requalified and the room<br />
data sheet of the affected area shall<br />
be updated to incorporate the change(s)<br />
made.<br />
2. Any change made in the existing area<br />
support services or new or additional<br />
features are added to the room.<br />
Discussions and Summary<br />
From the data compiled, a summary<br />
report shall be prepared. Corporate technical<br />
team shall review and approve the final<br />
summary report prior to handling of the<br />
building <strong>for</strong> regular use.<br />
Attachments<br />
The following documents should be kept<br />
as an attachment with the facility validation<br />
protocol and report and should be updated<br />
with the justification of modification and<br />
changes:<br />
1. Approved Drawings<br />
2. Door Specifications<br />
3. Certificates<br />
A specific process will consistently<br />
produce a product meeting predetermined<br />
specifications and quality attributes. This<br />
constitutes Process <strong>Validation</strong> (PV) or<br />
Process Per<strong>for</strong>mance Qualification (PPQ).<br />
<strong>Facility</strong> validation covers all aspects<br />
of product and process risk management<br />
but after complying the facility qualification<br />
requirements, it is mandatory to the<br />
manufacturer to review periodically the<br />
facility qualification status. Generally, it<br />
has been observed that it is assumed by<br />
pharmaceutical manufacturers that once<br />
the facility is qualified, it will remain qualified<br />
throughout the life cycle of his business.<br />
But, at a particular juncture they realize<br />
that their world class manufacturing facility<br />
has become outdated and cannot be used<br />
anymore <strong>for</strong> the manufacturing purpose of<br />
medicinal products. The manufacturers of<br />
pharmaceuticals will have to bear in mind<br />
that what is prevalent today can become<br />
obsolete tomorrow and we have to keep<br />
pace with the changes taking place globally<br />
to remain in business <strong>for</strong>ever.<br />
Positions<br />
Advertisement Tariff <strong>for</strong><br />
Pharma Times<br />
New rates effective from 1/4/10<br />
For Color<br />
page<br />
(Rs.) Per<br />
insertion<br />
For B/W page<br />
(Rs.) Per<br />
Insertion<br />
Front Cover Gate Fold 50,000.00 –<br />
Back Cover 44,000.00 –<br />
Inside Front 30,000.00 –<br />
Inside Back 28,000.00 –<br />
First Page (Page 3) 30,000.00 –<br />
Last Page (Opp. Inside Back) 20,000.00 –<br />
Page Facing Content & Editorial Note 20,000.00 –<br />
Double Spread (Or Centre Spread) 35,000.00 –<br />
Full Page 16,000.00 10,000.00<br />
Half Page 9,000.00 6,000.00<br />
Quarter Page 5,000.00 3,500.00<br />
Discount <strong>for</strong> 1 to 3 insertion - 15%<br />
Discount <strong>for</strong> 4 to 6 insertions - 20%<br />
Discount <strong>for</strong> 7 to 12 insertions - 25%<br />
For Advertisements<br />
Mr. Ramesh Shah<br />
M/s. Kantilal N. Shah<br />
702, Corporate House, Opp. Dinesh Hall, Income Tax,<br />
Ashram Road, Ahmedabad - 380009, Gujarat.<br />
Ph.: 079-27540493, Fax: 079-30023754, Mobile: +91 93777 46368<br />
E-mail: kns_98@yahoo.com, kantilalnshah@gmail.com,<br />
Website: www.knsmedia.com<br />
Payment advance <strong>for</strong> every issue in the name of “M/s. Kantilal N. Shah”.<br />
Announcement<br />
National seminar<br />
On “Recent Advances in Drug Development & Research”<br />
On 03 rd March 2012 (Saturday)<br />
At P.D.M. College of Pharmacy,<br />
Sector- 3A, BahadurGarh<br />
Contact:<br />
Prof. (Dr.) Arun Garg - 09416056213<br />
Mr. Permender Rathee 09466593965<br />
Email id: pdmcop@rediffmail.com<br />
Advertisers’ Index<br />
Sr. No. Company Name Page No.<br />
1. Accin Packaging Pvt. Ltd................................................46<br />
2. Accupack Engineering Pvt. Ltd.......................................47<br />
3. Adam Fabriwerk Pvt. Ltd.................................................42<br />
4. Ambica Pharma Machines Pvt. Ltd.................................49<br />
5. Ami Polymer Pvt. Ltd.......................................................43<br />
6. Bectochem Consultants & Engineers Pvt. Ltd................44<br />
7. Bector Hecht Containment Technology Pvt. Ltd.............45<br />
8. Brothers Pharmamach (India) Pvt. Ltd............................10<br />
9. Cadmach Machinery Co. Pvt. Ltd...................................41<br />
10. Centre <strong>for</strong> Clinical Research & Training..........................40<br />
11. Dipesh Engineering Works................................................5<br />
12. Elmach Packages (India) Pvt. Ltd........................26,27, 50<br />
13. Fabtech Technologies International Ltd...................2,3,6,8<br />
14. Gitam University..............................................................40<br />
15. IMA-PG India Pvt Ltd........................................................4<br />
16. N. K. P. Pharma Pvt. Ltd.................................................25<br />
17. Precitech industries.........................................................28<br />
18. Promas Engineers Pvt. Ltd.............................................48<br />
19. Sanira Associates...........................................................28<br />
20. Target Innovations..........................................................43<br />
Pharma Times - Vol. 44 - No. 02 - February 2012 14